Need professional-grade analysis? Visit stockanalysis.com
$10.13B
N/A
1,774
N/A
Jiangxi Fushine Pharmaceutical Co Ltd (300497) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY18.84, down 0.63% from the previous close.
Over the past year, 300497 has traded between a low of CNY8.30 and a high of CNY21.15. The stock has gained 124.3% over this period. It is currently 10.9% below its 52-week high.
Jiangxi Fushine Pharmaceutical Co Ltd has a market capitalization of $10.13B.
Jiangxi Fushine Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers ß-lactamase inhibitors, carbapenem antibiotics, and antiviral drug intermediates; argatroban injection for the treatment of acute ischemic stroke; and doxycycline hydrochloride dispersible tablets to treat rickettsial diseases, mycoplasmal and chlamydial infections, relapsing fever, brucellosis, cholera, tularemia, plague, and chancroid. It also provides lithium-ion battery electrolyte additives; and microbial protein, amino acid water-soluble fertilizer, and other bio-fermentation products. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Jingdezhen, China.
Side-by-side comparison against top Healthcare peers.